APA
Beelen D. W., Trenschel R., Stelljes M., Groth C., Masszi T., Reményi P., Wagner-Drouet E., Hauptrock B., Dreger P., Luft T., Bethge W., Vogel W., Ciceri F., Peccatori J., Stölzel F., Schetelig J., Junghanß C., Grosse-Thie C., Michallet M., Labussiere-Wallet H., Schaefer-Eckart K., Dressler S., Grigoleit G. U., Mielke S., Scheid C., Holtick U., Patriarca F., Medeot M., Rambaldi A., Micò M. C., Niederwieser D., Franke G., Hilgendorf I., Winkelmann N. R., Russo D., Socié G., Peffault de Latour R., Holler E., Wolff D., Glass B., Casper J., Wulf G., Menzel H., Basara N., Bieniaszewska M., Stuhler G., Verbeek M., Grass S., Iori A. P., Finke J., Benedetti F., Pichlmeier U., Hemmelmann C., Tribanek M., Klein A., Mylius H. A., Baumgart J., Dzierzak-Mietla M. & Markiewicz M. (20200103). Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. : The Lancet. Haematology.
Chicago
Beelen Dietrich Wilhelm, Trenschel Rudolf, Stelljes Matthias, Groth Christoph, Masszi Tamás, Reményi Péter, Wagner-Drouet Eva-Maria, Hauptrock Beate, Dreger Peter, Luft Thomas, Bethge Wolfgang, Vogel Wichard, Ciceri Fabio, Peccatori Jacopo, Stölzel Friedrich, Schetelig Johannes, Junghanß Christian, Grosse-Thie Christina, Michallet Mauricette, Labussiere-Wallet Hélène, Schaefer-Eckart Kerstin, Dressler Sabine, Grigoleit Goetz Ulrich, Mielke Stephan, Scheid Christof, Holtick Udo, Patriarca Francesca, Medeot Marta, Rambaldi Alessandro, Micò Maria Caterina, Niederwieser Dietger, Franke Georg-Nikolaus, Hilgendorf Inken, Winkelmann Nils Rudolf, Russo Domenico, Socié Gérard, Peffault de Latour Régis, Holler Ernst, Wolff Daniel, Glass Bertram, Casper Jochen, Wulf Gerald, Menzel Helge, Basara Nadezda, Bieniaszewska Maria, Stuhler Gernot, Verbeek Mareike, Grass Sandra, Iori Anna Paola, Finke Juergen, Benedetti Fabio, Pichlmeier Uwe, Hemmelmann Claudia, Tribanek Michael, Klein Anja, Mylius Heidrun Anke, Baumgart Joachim, Dzierzak-Mietla Monika and Markiewicz Miroslaw. 20200103. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. : The Lancet. Haematology.
Harvard
Beelen D. W., Trenschel R., Stelljes M., Groth C., Masszi T., Reményi P., Wagner-Drouet E., Hauptrock B., Dreger P., Luft T., Bethge W., Vogel W., Ciceri F., Peccatori J., Stölzel F., Schetelig J., Junghanß C., Grosse-Thie C., Michallet M., Labussiere-Wallet H., Schaefer-Eckart K., Dressler S., Grigoleit G. U., Mielke S., Scheid C., Holtick U., Patriarca F., Medeot M., Rambaldi A., Micò M. C., Niederwieser D., Franke G., Hilgendorf I., Winkelmann N. R., Russo D., Socié G., Peffault de Latour R., Holler E., Wolff D., Glass B., Casper J., Wulf G., Menzel H., Basara N., Bieniaszewska M., Stuhler G., Verbeek M., Grass S., Iori A. P., Finke J., Benedetti F., Pichlmeier U., Hemmelmann C., Tribanek M., Klein A., Mylius H. A., Baumgart J., Dzierzak-Mietla M. and Markiewicz M. (20200103). Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. : The Lancet. Haematology.
MLA
Beelen Dietrich Wilhelm, Trenschel Rudolf, Stelljes Matthias, Groth Christoph, Masszi Tamás, Reményi Péter, Wagner-Drouet Eva-Maria, Hauptrock Beate, Dreger Peter, Luft Thomas, Bethge Wolfgang, Vogel Wichard, Ciceri Fabio, Peccatori Jacopo, Stölzel Friedrich, Schetelig Johannes, Junghanß Christian, Grosse-Thie Christina, Michallet Mauricette, Labussiere-Wallet Hélène, Schaefer-Eckart Kerstin, Dressler Sabine, Grigoleit Goetz Ulrich, Mielke Stephan, Scheid Christof, Holtick Udo, Patriarca Francesca, Medeot Marta, Rambaldi Alessandro, Micò Maria Caterina, Niederwieser Dietger, Franke Georg-Nikolaus, Hilgendorf Inken, Winkelmann Nils Rudolf, Russo Domenico, Socié Gérard, Peffault de Latour Régis, Holler Ernst, Wolff Daniel, Glass Bertram, Casper Jochen, Wulf Gerald, Menzel Helge, Basara Nadezda, Bieniaszewska Maria, Stuhler Gernot, Verbeek Mareike, Grass Sandra, Iori Anna Paola, Finke Juergen, Benedetti Fabio, Pichlmeier Uwe, Hemmelmann Claudia, Tribanek Michael, Klein Anja, Mylius Heidrun Anke, Baumgart Joachim, Dzierzak-Mietla Monika and Markiewicz Miroslaw. Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial. : The Lancet. Haematology. 20200103.